Now is the Time to Scale Up Birth-Dose Hepatitis B Vaccine in Low- and Middle-Income Countries

3Citations
Citations of this article
20Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Fewer than half of the world’s infants have access to the birth dose of hepatitis B vaccine (HBV), which prevents mother-to-child transmission of HBV and subsequent liver cancer. Now is the time to expand access for infants born in low-resource settings.

Cite

CITATION STYLE

APA

Thompson, P., Parr, J. B., Boisson, A., Razavi-Shearer, D., Ezechi, O. C., Wang, S. H., & Tucker, J. D. (2023). Now is the Time to Scale Up Birth-Dose Hepatitis B Vaccine in Low- and Middle-Income Countries. Journal of Infectious Diseases, 228(4), 368–370. https://doi.org/10.1093/infdis/jiad026

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free